What is the official website of Corbion Bioplastics ?

The official website of Corbion Bioplastics is http://www.corbion.com/bioplastics.

What is Corbion Bioplastics's cybersecurity risk score?

Corbion Bioplastics has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Corbion Bioplastics experienced?

According to Rankiteo, Corbion Bioplastics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Corbion Bioplastics been affected by any supply chain cyber incidents ?

According to Rankiteo, Corbion Bioplastics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Corbion Bioplastics have SOC 2 Type 1 certification ?

According to Rankiteo, Corbion Bioplastics is not certified under SOC 2 Type 1.

Does Corbion Bioplastics have SOC 2 Type 2 certification ?

According to Rankiteo, Corbion Bioplastics does not hold a SOC 2 Type 2 certification.

Does Corbion Bioplastics comply with GDPR ?

According to Rankiteo, Corbion Bioplastics is not listed as GDPR compliant.

Does Corbion Bioplastics have PCI DSS certification ?

According to Rankiteo, Corbion Bioplastics does not currently maintain PCI DSS compliance.

Does Corbion Bioplastics comply with HIPAA ?

According to Rankiteo, Corbion Bioplastics is not compliant with HIPAA regulations.

Does Corbion Bioplastics have ISO 27001 certification ?

According to Rankiteo,Corbion Bioplastics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Corbion Bioplastics operate in ?

Corbion Bioplastics operates primarily in the Biotechnology Research industry.

How many employees does Corbion Bioplastics have ?

Corbion Bioplastics employs approximately None employees people worldwide.

Does Corbion Bioplastics own any subsidiaries ?

Corbion Bioplastics presently has no subsidiaries across any sectors.

How many LinkedIn followers does Corbion Bioplastics have ?

Corbion Bioplastics's official LinkedIn profile has approximately 1,753 followers.

What is the NAICS classification code for Corbion Bioplastics ?

Corbion Bioplastics is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Corbion Bioplastics have a Crunchbase profile ?

No, Corbion Bioplastics does not have a profile on Crunchbase.

Does Corbion Bioplastics have a LinkedIn profile ?

Yes, Corbion Bioplastics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/biobased-plastics.

How many cybersecurity incidents has Corbion Bioplastics experienced ?

As of October 16, 2026, Rankiteo reports that Corbion Bioplastics has not experienced any cybersecurity incidents.

How many peer or competitor companies does Corbion Bioplastics have ?

Corbion Bioplastics has an estimated 4,784 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Corbion Bioplastics

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Corbion Bioplastics Vendor Cyber Rating & Cyber Score

corbion.com

Add Your Compliance Badge

For info on our PLA Joint Venture, please follow the dedicated page at https://www.linkedin.com/company/total-corbion-pla

Corbion Bioplastics

Corbion Bioplastics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Corbion Bioplastics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Corbion Bioplastics

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Corbion Bioplastics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Corbion Bioplastics in 2026.

Incident Types Corbion Bioplastics vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Corbion Bioplastics in 2026.

Incident History - Corbion Bioplastics (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Corbion Bioplastics Subsidiaries

Corbion Bioplastics

Biotechnology Research

Website: http://www.corbion.com/bioplastics

Company Size: None employees

CorbionBiotechnology Research

Corbion FoodFood and Beverage Services

TotalEnergies CorbionPlastics Manufacturing

Corbion BiochemicalsBiotechnologisch onderzoek

Corbion BiomaterialsGeneesmiddelenproductie

Loading…

Corbion Bioplastics Similar Companies

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Loading…

NEWS

Corbion Bioplastics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

August 13, 2025 07:00 AM

Saudi Arabia Biodegradable Plastic Market Trends and Company Analysis Report 2025-2033 Featuring Total Corbion, Mitsubishi, Toray Industries, BASF, Green Dot Bioplastics, Amcor

The Saudi Arabia Biodegradable Plastic Market is projected to grow from US$ 78.65 million in 2024 to US$ 221.98 million by 2033,...

Read Article

January 23, 2025 08:00 AM

Bioplastics Market Research and Competition Analysis, 2025-2034 - BASF, Corbion, Danimer Scientific, Mitsubishi Chemical, and Novamont Lead Revenue Shares

Advanced Feedstock Sourcing, Bio-Based Materials for Durables, Industry Collaboration, and Carbon Neutrality Focus are Among the Top Trends...

Read Article

April 23, 2024 07:00 AM

TotalEnergies Corbion showcases Luminy PLA bioplastics at Chinaplas 2024

Poly lactic acid (PLA) bioplastics are gaining significant traction in China as the country continues to prioritize sustainability and...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-111369

SUMMARY

ClassroomIO through 1.0.0 contains an incorrect authorization vulnerability in the PUT and DELETE /:lessonId lesson routes that allows any course member, including students, to modify lessons. Authenticated students can supply arbitrary lesson ids to change titles and stored HTML content or delete lessons in their course and in other courses and organizations.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:L

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-111368

SUMMARY

ClassroomIO through 1.0.0 contains an insecure direct object reference vulnerability in the Hono API course submission routes that allows course tutors or admins to modify submissions in other courses. Attackers can supply their own course id with another course's submission UUID to PUT or DELETE handlers to overwrite answers, grades, feedback, and grading status or delete submissions.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 6.4)

cvss3

Base Score: 6.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:H/A:L

cvss4

Base Score: 6.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.7

Exploitability

1.6

REFERENCES

CVE-2026-111367

SUMMARY

BillionMail through 4.9 contains a hard-coded cryptographic key vulnerability that allows unauthenticated attackers to forge unsubscribe and subscribe-confirm JWTs by computing the key from shipped configuration constants. Attackers can submit forged tokens to /api/unsubscribe, /api/unsubscribe_new, or /api/subscribe/confirm to deactivate any contact or force confirmed subscriptions.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-111366

SUMMARY

cool-admin-midway through 8.0.0 contains an authorization bypass vulnerability that allows department-limited admins to manage users outside their departments by supplying arbitrary user ids. Attackers holding sys:user:* permissions can call /admin/sys/user/info, update, or delete to read records, reset passwords and roles, or delete accounts.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.2

REFERENCES

CVE-2026-111365

SUMMARY

cool-admin-midway through 8.0.0 contains an authorization bypass vulnerability that allows non-superadmin admins to read, modify, or delete other admins' roles by supplying arbitrary role ids. Attackers holding ordinary sys:role permissions can call /admin/sys/role/info, update, or delete with another admin's role id to rewrite menu and department grants, changing other users' effective access.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 6)

cvss3

Base Score: 6.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:H/A:L

cvss4

Base Score: 7.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.7

Exploitability

1.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Corbion Bioplastics Vendor Cyber Rating & Cyber Score

Corbion Bioplastics A.I CyberSecurity Scoring

Corbion Bioplastics CyberSecurity News & History

Corbion Bioplastics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Corbion Bioplastics

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Corbion Bioplastics vs Biotechnology Research Industry Avg (This Year)

Incident History - Corbion Bioplastics (X = Date, Y = Severity)

Corbion Bioplastics Subsidiaries

Corbion Bioplastics

Corbion Bioplastics Similar Companies

Avantor

bioMérieux

Syneos Health

Eurofins

Agilent Technologies

CSL

Fortrea

Amgen

Genentech

Corbion Bioplastics CyberSecurity News

Saudi Arabia Biodegradable Plastic Market Trends and Company Analysis Report 2025-2033 Featuring Total Corbion, Mitsubishi, Toray Industries, BASF, Green Dot Bioplastics, Amcor

Bioplastics Market Research and Competition Analysis, 2025-2034 - BASF, Corbion, Danimer Scientific, Mitsubishi Chemical, and Novamont Lead Revenue Shares

TotalEnergies Corbion showcases Luminy PLA bioplastics at Chinaplas 2024

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Corbion Bioplastics CyberSecurity News & History

Corbion Bioplastics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Corbion Bioplastics

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Corbion Bioplastics vs Biotechnology Research Industry Avg (This Year)

Incident History - Corbion Bioplastics (X = Date, Y = Severity)

Corbion Bioplastics Subsidiaries

Corbion Bioplastics

Corbion Bioplastics Similar Companies

Avantor

bioMérieux

Syneos Health

Eurofins

Agilent Technologies

CSL

Fortrea

Amgen

Genentech

Corbion Bioplastics CyberSecurity News

Saudi Arabia Biodegradable Plastic Market Trends and Company Analysis Report 2025-2033 Featuring Total Corbion, Mitsubishi, Toray Industries, BASF, Green Dot Bioplastics, Amcor

Bioplastics Market Research and Competition Analysis, 2025-2034 - BASF, Corbion, Danimer Scientific, Mitsubishi Chemical, and Novamont Lead Revenue Shares

TotalEnergies Corbion showcases Luminy PLA bioplastics at Chinaplas 2024

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo